Cantor Fitzgerald Lowers Exagen (NASDAQ:XGN) Price Target to $7.00
Exagen (NASDAQ:XGN – Get Free Report) had its target price dropped by equities research analysts at Cantor Fitzgerald from $8.00 to $7.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 16.47% from the stock’s current price. Several […]
Exagen (NASDAQ:XGN – Get Free Report) had its target price dropped by equities research analysts at Cantor Fitzgerald from $8.00 to $7.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 16.47% from the stock’s current price. Several […]
-inc-logo-1200x675.PNG?v=20210312142656&w=240&h=240&zc=2){kind=logo}
